Related Experiment Videos
Influence of the anti-inflammatory compound flosulide on granulocyte function
W Zimmerli1, S Sansano, I Wiesenberg-Böttcher
1Department of Research, University Hospital, Basel, Switzerland.
Biochemical Pharmacology
|October 24, 1991
Summary
Flosulide, a potent anti-inflammatory drug, effectively inhibits superoxide production in polymorphonuclear leukocytes (PMN) without hindering bacterial killing. This compound shows promise in treating inflammatory conditions by targeting free radical generation.
Area of Science:
- Pharmacology
- Immunology
- Inflammation Research
Background:
- Polymorphonuclear leukocytes (PMN) play a role in inflammation.
- Oxygen-derived free radicals from PMN may cause tissue damage during inflammation.
Purpose of the Study:
- To investigate the anti-inflammatory effects of flosulide.
- To determine flosulide's impact on superoxide production in PMN.
Main Methods:
- Assessing superoxide production inhibition by flosulide and metabolites using N-formyl-Met-Leu-Phe (FMLP), C5a, and PMA.
- Comparing flosulide's potency to nimesulide.
- Evaluating effects on bacterial killing, chemotaxis, and FMLP receptor binding.
- Correlating in vitro findings with in vivo anti-inflammatory activity in rat adjuvant arthritis.
Main Results:
- Flosulide potently inhibited FMLP-induced superoxide production in PMN, surpassing nimesulide.
- Flosulide and its metabolites inhibited superoxide generation without affecting bacterial killing or chemotaxis.
- A strong correlation was observed between in vitro inhibition and in vivo anti-inflammatory potency.
- Flosulide reduced FMLP receptor number but did not displace FMLP from the receptor.
Conclusions:
- Flosulide is a potent inhibitor of PMN superoxide production, a key factor in inflammatory tissue damage.
- Flosulide's mechanism involves modulating FMLP receptor interactions.
- Flosulide and its metabolites demonstrate significant anti-inflammatory potential, supported by both in vitro and in vivo data.